DE60205125D1 - Feste zubereitungen mit ramipril - Google Patents

Feste zubereitungen mit ramipril

Info

Publication number
DE60205125D1
DE60205125D1 DE60205125T DE60205125T DE60205125D1 DE 60205125 D1 DE60205125 D1 DE 60205125D1 DE 60205125 T DE60205125 T DE 60205125T DE 60205125 T DE60205125 T DE 60205125T DE 60205125 D1 DE60205125 D1 DE 60205125D1
Authority
DE
Germany
Prior art keywords
ramipril
solid preparations
hydrate
mixture
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60205125T
Other languages
English (en)
Other versions
DE60205125T2 (de
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4170122&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60205125(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60205125D1 publication Critical patent/DE60205125D1/de
Publication of DE60205125T2 publication Critical patent/DE60205125T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Road Signs Or Road Markings (AREA)
  • Food-Manufacturing Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60205125T 2001-09-28 2002-09-12 Feste zubereitungen mit ramipril Expired - Fee Related DE60205125T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2357982 2001-09-28
CA002357982A CA2357982A1 (en) 2001-09-28 2001-09-28 Solid compositions comprising ramipril
PCT/CA2002/001379 WO2003028707A1 (en) 2001-09-28 2002-09-12 Solid compositions comprising ramipril

Publications (2)

Publication Number Publication Date
DE60205125D1 true DE60205125D1 (de) 2005-08-25
DE60205125T2 DE60205125T2 (de) 2006-05-24

Family

ID=4170122

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60205125T Expired - Fee Related DE60205125T2 (de) 2001-09-28 2002-09-12 Feste zubereitungen mit ramipril

Country Status (6)

Country Link
US (1) US20050169981A1 (de)
EP (1) EP1429748B1 (de)
AT (1) ATE299697T1 (de)
CA (1) CA2357982A1 (de)
DE (1) DE60205125T2 (de)
WO (1) WO2003028707A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2394660A (en) * 2003-12-17 2004-05-05 Niche Generics Ltd Stabilisation of pharmaceutical compositions comprising ACE inhibitor by absence of acidic excipients having large specific surface area, eg silicon dioxide
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
WO2005067887A2 (en) * 2004-03-24 2005-07-28 Actavis Group Formulations of ramipril
ES2603856T3 (es) 2004-03-29 2017-03-01 Les Laboratoires Servier Procedimiento para preparar una composición farmacéutica sólida
KR100593795B1 (ko) * 2004-10-12 2006-06-30 대원제약주식회사 안정성이 개선된 라미프릴을 포함하는 경구투여용 제제
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
TR200906322A2 (tr) 2009-08-17 2011-07-21 Bi̇lgi̇ç Mahmut Çözünürlük ve stabilite özellikleri geliştirilmiş granüller.
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
PL227900B1 (pl) 2012-11-15 2018-01-31 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
DE4420102A1 (de) * 1994-06-09 1995-12-14 Asta Medica Ag Arzneimittelkombinationen aus alpha-Liponsäure und herz-kreislaufaktiven Substanzen
CA2128199C (en) * 1994-07-15 1997-02-04 Bernard Charles Sherman Stable solid pharmaceutical compositions containing enalapril maleate
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
NZ333206A (en) * 1998-12-08 2000-07-28 Bernard Charles Sherman Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor
DE10038364A1 (de) * 2000-08-05 2002-05-02 Hexal Ag Pharmazeutische, Ramipril enthaltende Brauseformulierung

Also Published As

Publication number Publication date
EP1429748A1 (de) 2004-06-23
DE60205125T2 (de) 2006-05-24
US20050169981A1 (en) 2005-08-04
EP1429748B1 (de) 2005-07-20
ATE299697T1 (de) 2005-08-15
CA2357982A1 (en) 2003-03-28
WO2003028707A1 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
DE60205125D1 (de) Feste zubereitungen mit ramipril
PT1412384E (pt) Formulação estável de glp-1 modificado
HUP0101237A1 (hu) Elnyújtott kioldódású gyógyszerkészítmények
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
GEP20074047B (en) Pramipexole once-daily dosage form
WO2004043363A3 (en) Protein-stabilized liposomal formulations of pharmaceutical agents
MXPA03006476A (es) Composiciones farmaceuticas, formas de dosificacion y metodos para administracion oral de epotilonas.
CY1108522T1 (el) Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
BR0210078A (pt) Composto, uso do mesmo, e, formulação farmacêutica
EE04911B1 (et) Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks
EA200401517A1 (ru) Фармацевтический препарат для местного применения
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
EA200300937A1 (ru) Оральная фармацевтическая композиция цефподоксима проксетила
EA200301223A1 (ru) Лекарственные формы окскарбазепина
HUP0104647A2 (hu) Hatóanyagként tilidin-mezilátot tartalmazó, szabályozott hatóanyag-leadású gyógyszerkészítmény
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
RS53804A (en) Parenteral composition of paracetamol
DE50105771D1 (de) Ibuprofen-wirkstoffzubereitung
DK1105105T3 (da) Oral administrationsform til pyridin-2-ylmethylsulfinyl-1H-benzimidazoler
NO20014855D0 (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
HUP0202592A2 (hu) Lazofoxifen transzdermális adagolása

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee